Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UTS2R | Q9UKP6 | 7/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.48 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.47 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.47 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.47 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propanocaine SCHEMBL24544 | 1.00 | UTS2R (0.54) | UTS2RLMNACYP1A2CYP2D6ALDH1A1 | |
| Propanocaine SCHEMBL4180296 | 0.99 | UTS2R (0.53) | UTS2RLMNACYP1A2CYP2D6ALDH1A1 | |
| Propanocaine SCHEMBL4180298 | 0.99 | UTS2R (0.53) | UTS2RLMNACYP1A2CYP2D6ALDH1A1 | |
| Elucaine SCHEMBL635291 | 0.85 | ALDH1A1 (0.46) | UTS2RLMNACYP1A2CYP2D6ALDH1A1 | |
| SCHEMBL27399397 | 0.83 | UTS2R (0.50) | UTS2RLMNAALDH1A1CYP3A4MAPT | |
| SCHEMBL1785848 | 0.80 | TSHR (0.52) | UTS2RLMNAALDH1A1SIGMAR1MAPT | |
| SCHEMBL3817682 | 0.80 | TSHR (0.52) | UTS2RLMNAALDH1A1CYP3A4SMN1; SMN2 | |
| SCHEMBL2455385 | 0.79 | ALDH1A1 (0.48) | UTS2RLMNAALDH1A1SMN1; SMN2SIGMAR1 | |
| SCHEMBL9341086 | 0.78 | ALDH1A1 (0.50) | UTS2RLMNAALDH1A1SMN1; SMN2SIGMAR1 | |
| SCHEMBL28637211 | 0.78 | UTS2R (0.51) | UTS2RLMNACYP1A2ALDH1A1SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1894 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260115156-A1 | INJECTABLE COMPOSITION INCLUDING HYDROGEL CONTAINING ANESTHETIC AGENT | UNIV KOREA RES & BUS FOUND (KR) | 2026-04-30 | — | — | US | claimed |
| EP-4436552-B1 | GASTRO-RETENTIVE ORAL DOSAGE UNIT CONTAINING A LOCAL ANAESTHETIC | OREXA B V (NL) | 2026-02-04 | — | — | EP | claimed |
| WO-2025235864-A1 | COATED NEEDLE ADMINISTRATION SYSTEMS | EVOLUS, INC. (US) | 2025-11-13 | — | — | WO | claimed |
| EP-4578441-A1 | TREATMENT OF LOCALIZED PAIN | PlantTec Medical GmbH (DE) | 2025-07-02 | — | — | EP | claimed |
| US-12329856-B2 | Crosslinked hyaluronic acid composition with local anesthetics | BIOPOLIMERI S.R.L. (IT) | 2025-06-17 | — | — | US | claimed |
| US-20250186364-A1 | COMBINATION OF ANTISPASMODIC AND ANESTHETIC AGENTS FOR TOPICAL PRODUCTS AND THEIR METHOD OF USE | PRIMA INNOVATIONS, LLC | 2025-06-12 | — | — | US | claimed |
| EP-4362994-B1 | CROSSLINKED HYALURONIC ACID COMPOSITION WITH LOCAL ANESTHETICS | BIOPOLIMERI S R L (IT) | 2025-03-12 | — | — | EP | claimed |
| WO-2025043048-A1 | METHODS AND SYSTEMS FOR DELIVERY OF MODIFIED AGAROSE POLYSACCHARIDES | RELIVE THERAPEUTICS INC. (US) | 2025-02-27 | — | — | WO | claimed |
| US-20250009689-A1 | GASTRO-RETENTIVE ORAL DOSAGE UNIT CONTAINING A LOCAL ANAESTHETIC | OREXA B.V. (NL) | 2025-01-09 | — | — | US | claimed |
| EP-3703802-B9 | NASAL DELIVERY DEVICES AND METHODS OF USE THEREOF | CLEXIO BIOSCIENCES LTD (IL) | 2024-12-04 | — | — | EP | claimed |
| US-6297290-B2 | INTENDED TO ANESTHETIZE THE SKIN OR THE MUCOUS MEMBRANES OR TO TREAT PRURITUS. | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOQUES GALDERMA (C.I.R.D. GALDERMA) (FR) | 2001-10-02 | — | — | US | claimed |
| EP-1027015-A4 | CONTROLLED RELEASE OF PHARMACEUTICALS IN THE ANTERIOR CHAMBER OF THE EYE | GALIN MILES A (US) | 2001-06-27 | — | — | EP | claimed |
| WO-2001043733-A2 | COMPOSITIONS, KITS, APPARATUS, AND METHODS FOR INHIBITING CEPHALIC INFLAMMATION | LEVIN BRUCE H (US) | 2001-06-21 | — | — | WO | claimed |
| US-20010004644-A1 | Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation | LEVIN BRUCE H (US) | 2001-06-21 | — | — | US | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| EP-1027015-A1 | CONTROLLED RELEASE OF PHARMACEUTICALS IN THE ANTERIOR CHAMBER OF THE EYE | Galin, Miles A. (US) | 2000-08-16 | — | — | EP | claimed |
| US-5972326-A | Controlled release of pharmaceuticals in the anterior chamber of the eye | IOLTECH (FR) | 1999-10-26 | — | — | US | claimed |
| WO-1998041171-A1 | CONTROLLED RELEASE OF PHARMACEUTICALS IN THE ANTERIOR CHAMBER OF THE EYE | GALIN MILES A (US) | 1998-09-24 | — | — | WO | claimed |
| US-4041174-A | INJECTING AN ESTER LOCAL ANESTHETIC | ROM-AMER PHARMACEUTICALS, LTD. (US) | 1977-08-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12329856-B2 | Crosslinked hyaluronic acid composition with local anesthetics | CD44, HCAR3, HCAR2 | UTS2R 3586/4885LMNA 1981/4885CYP1A2 1332/4885 |
| US-20010004644-A1 | Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation | CXCR5, CCL5, C5AR2 | UTS2R 2610/4885LMNA 1480/4885CYP1A2 1652/4885 |
| US-20260115156-A1 | INJECTABLE COMPOSITION INCLUDING HYDROGEL CONTAINING ANESTHETIC AGENT | CES2, DAGLA, ACHE | UTS2R 4771/4885LMNA 1300/4885CYP1A2 1231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.